Search Result
Results for "
N-desmethyl
" in MedChemExpress (MCE) Product Catalog:
2
Biochemical Assay Reagents
52
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-12388A
-
desmethylclomipramine hydrochloride; Norclomipramine hydrochloride
|
Drug Metabolite
|
Neurological Disease
|
N-Desmethyl Clomipramine hydrochloride (Desmethylclomipramine hydrochloride) is a primary plasma N-desmethyl metabolite of Clomipramine. Clomipramine is a tricyclic antidepressant .
|
-
-
- HY-70002A
-
N-desmethyl MDV 3100
|
Androgen Receptor
|
Cancer
|
N-desmethyl Enzalutamide is the active metabolite of Enzalutamide.N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
|
-
-
- HY-70002AS
-
N-desmethyl MDV 3100-d6
|
Androgen Receptor
|
Cancer
|
N-desmethyl Enzalutamide-d6 is a deuterium labeled N-desmethyl Enzalutamide. N-desmethyl Enzalutamide is an active metabolite of Enzalutamide. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
|
-
-
- HY-12388AS
-
desmethylclomipramine-d3 hydrochloride;Norclomipramine-d3 hydrochloride
|
Drug Metabolite
|
Neurological Disease
|
N-Desmethyl Clomipramine-d3 (hydrochloride) is the deuterium labeled N-Desmethyl Clomipramine. N-Desmethyl Clomipramine hydrochloride (Desmethylclomipramine hydrochloride) is a primary plasma N-desmethyl metabolite of Clomipramine
|
-
-
- HY-160849
-
|
GABA Receptor
|
Others
Metabolic Disease
|
N-desmethyl Rilmazolam, a triazolobenzodiazepine, serves as an analytical reference standard. N-desmethyl Rilmazolam is an active metabolite derived from rilmazafone (HY-106547). N-desmethyl Rilmazolam is designed for use in research and forensic settings .
|
-
-
- HY-70002AR
-
|
Androgen Receptor
|
Cancer
|
N-desmethyl Enzalutamide (Standard) is the analytical standard of N-desmethyl Enzalutamide. This product is intended for research and analytical applications. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide.N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
|
-
-
- HY-G0010
-
-
-
- HY-137200
-
|
Drug Metabolite
|
Cancer
|
N-Desmethyl Bendamustine is a metabolite of Bendamustine (HY-13567). N-Desmethyl Bendamustine has cytotoxic effect in several lymphoma cell lines and peripheral blood lymphocytes .
|
-
-
- HY-W013775R
-
|
Biochemical Assay Reagents
Reference Standards
|
Others
|
N-Desmethyl ofloxacin (Standard) is the analytical standard of N-Desmethyl ofloxacin. This product is intended for research and analytical applications. N-Desmethyl ofloxacin is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
-
-
- HY-142283BS
-
|
EGFR
|
Cancer
|
N-Desmethyl dosimertinib-d5 is the deuterium labeled N-Desmethyl dosimertinib.
|
-
-
- HY-G0017
-
Norimatinib; Imatinib metabolite N-desmethyl imatinib
|
Drug Metabolite
|
Cancer
|
N-Desmethyl imatinib (Norimatinib) is a c-Abl tyrosine kinase inhibitor. N-Desmethyl imatinib binds to the c-Abl catalytic domain to prevent substrate phosphorylation, inhibits c-Abl-mediated α-synuclein activation and downstream inflammatory signaling pathways, and inhibits c-Abl-related neurodegenerative activity and neuroinflammation in vitro. N-Desmethyl imatinib can be used to study neurodegenerative diseases (such as Parkinson's disease) .
|
-
-
- HY-144143S
-
-
-
- HY-158192S
-
-
-
- HY-143922S
-
-
-
- HY-132626S
-
-
-
- HY-141750S1
-
-
-
- HY-132685S
-
-
-
- HY-132685AS
-
-
-
- HY-132344S
-
-
-
- HY-139519S
-
-
-
- HY-132653S
-
-
-
- HY-G0010S
-
-
-
- HY-W754151
-
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl apalutamide-d4 is the deuterium-labeled N-Desmethyl-Apalutamide (HY-135331). N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration .
|
-
-
- HY-W741222S
-
-
-
- HY-143810S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl Mifepristone-d3 is the deuterium labeled N-Desmethyl Mifepristone . N-Desmethyl Mifepristone is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
-
- HY-W740049
-
-
-
- HY-143767S
-
-
-
- HY-Z3203S
-
-
-
- HY-143931S
-
-
-
- HY-108226
-
N-desmethyl regorafenib N-oxide
|
Drug Metabolite
Raf
VEGFR
c-Kit
|
Cancer
|
Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
-
- HY-W662579
-
-
-
- HY-12388AR
-
desmethylclomipramine hydrochloride (Standard); Norclomipramine hydrochloride (Standard)
|
Reference Standards
Drug Metabolite
|
Neurological Disease
|
N-Desmethyl Clomipramine (hydrochloride) (Standard) is the analytical standard of N-Desmethyl Clomipramine (hydrochloride). This product is intended for research and analytical applications. N-Desmethyl Clomipramine hydrochloride (Desmethylclomipramine hydrochloride) is a primary plasma N-desmethyl metabolite of Clomipramine. Clomipramine is a tricyclic antidepressant .
|
-
-
- HY-G0017A
-
Norimatinib mesylate; Imatinib metabolite N-desmethyl imatinib mesylate
|
Drug Metabolite
|
Others
|
N-Desmethyl imatinib mesylate (Norimatinib mesylate) is a metabolite of Imatinib (HY-15463). Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR .
|
-
-
- HY-W013775
-
|
Biochemical Assay Reagents
|
Others
|
N-Desmethyl ofloxacin is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
-
-
- HY-Z8033
-
|
Cytochrome P450
|
Metabolic Disease
|
N-Desmethyl diltiazem hydrochloride is a substrate for CYP3A7 metabolism, which is the predominant fetal form and is minimally expressed in adults .
|
-
-
- HY-G0017S
-
Norimatinib-d8; Imatinib metabolite N-desmethyl imatinib-d8
|
Drug Metabolite
|
Cancer
|
N-Desmethyl imatinib-d8 is a deuterium labeled Imatinib metabolite N-Desmethyl Imatinib.
|
-
-
- HY-W295339S
-
-
-
- HY-100647S
-
-
-
- HY-172004
-
|
5-HT Receptor
|
Neurological Disease
|
N-Desmethyl asenapine is a metabolite of Asenapine (HY-10121). Asenapine, an atypical antipsychotic agent, is an antagonist of serotonin receptors, adrenoceptors, dopamine receptors and histamine receptors .
|
-
-
- HY-W709612
-
N-desmethyl regorafenib N-oxide-d3-1
|
Isotope-Labeled Compounds
VEGFR
Raf
c-Kit
Drug Metabolite
|
Cancer
|
Regorafenib N-oxide and N-desmethyl (M5)-d3-1 (N-Desmethyl regorafenib N-oxide-d3-1) is the deuterium labeled Regorafenib N-oxide and N-desmethyl (M5) (HY-108226). Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
-
- HY-120422S
-
-
-
- HY-144386S
-
-
-
- HY-G0017S1
-
Norimatinib-d4; Imatinib metabolite N-desmethyl imatinib-d4
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl imatinib-d4 is the deuterium-labeled N-Desmethyl imatinib (HY-G0017). N-Desmethyl imatinib-d4 (Norimatinib) is a metabolite of Imatinib (HY-15463). Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR .
|
-
-
- HY-108226S
-
N-desmethyl regorafenib N-oxide-d3
|
Isotope-Labeled Compounds
|
Others
|
Regorafenib N-oxide and N-desmethyl (M5)-d3 is deuterium labeled Regorafenib N-oxide and N-desmethyl (M5).
|
-
-
- HY-137580
-
|
Cytochrome P450
|
Metabolic Disease
|
N-desmethyl Eletriptan is a metabolite of Eletriptan (HY-A0039). It is formed from eletriptan primarily by the cytochrome P450 (CYP) isoform CYP3A4 in human liver microsomes.
|
-
-
- HY-N7612
-
N-Norgalanthamine
|
Cholinesterase (ChE)
|
Others
|
N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM .
|
-
-
- HY-118788S
-
-
-
- HY-118601S
-
-
-
- HY-W741626
-
-
-
- HY-117605R
-
desmethylsildenafil (Standard); UK-103,320 (Standard)
|
Reference Standards
Phosphodiesterase (PDE)
|
Cardiovascular Disease
|
N-Desmethyl Sildenafil (Standard) is the analytical standard of N-Desmethyl Sildenafil. This product is intended for research and analytical applications. N-Desmethyl Sildenafil (Desmethylsildenafil) is a major metabolite of Sildenafil. Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor .
|
-
- HY-U00199S
-
-
- HY-150544S
-
(-)-N-desmethylselegiline-d5 hydrochloride
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl Selegiline-dd5 hydrochloride is the deuterium labeled N-Desmethyl Selegiline hydrochloride . N-Desmethyl Selegiline-d5 hydrochloride is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
- HY-135392
-
AC-279
|
Drug Metabolite
|
Neurological Disease
|
N-Desmethyl Pimavanserin is the active metabolite of Pimavanserin. Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.
|
-
- HY-117605
-
desmethylsildenafil; UK-103,320
|
Phosphodiesterase (PDE)
|
Cardiovascular Disease
|
N-Desmethyl Sildenafil (Desmethylsildenafil) is a major metabolite of Sildenafil. Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor .
|
-
- HY-135392S
-
AC-279-d9 hydrochloride
|
Isotope-Labeled Compounds
|
Neurological Disease
|
N-Desmethyl Pimavanserin-d9 hydrochloride (AC-279-d9 hydrochloride) is the deuterium labeled N-Desmethyl Pimavanserin (HY-135392). N-Desmethyl Pimavanserin is the active metabolite of Pimavanserin. Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively .
|
-
- HY-171459
-
N-desmethyl Ribociclib
|
Drug Metabolite
Cytochrome P450
|
Cancer
|
LEQ803 (N-Desmethyl Ribociclib) is a drug metabolite of the CDK4/6 inhibitor Ribociclib (HY-15777), which is produced through metabolism by CYP3A4. LEQ803 has potential application value in the field of oncology .
|
-
- HY-W740014
-
183C91; DZT
|
5-HT Receptor
|
Neurological Disease
|
N-Desmethyl Zolmitriptan (183C91; DZT) is the active metabolite of the serotonin (5-HT) receptor subtype 5-HT1B and 5-HT1D agonist Zolmitriptan (HY-B0229). N-Desmethyl Zolmitriptan (183C91; DZT) is an agonist of 5-HT1B receptors and induces constriction in isolated human cerebral arteries (EC50=100 nM).
|
-
- HY-W740183
-
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl prochlorperazine dimaleate-d8 is the deuterium labeled 2-Chloro-10-(3-(piperazin-1-yl)propyl)-10H-phenothiazine (HY-W722908).
|
-
- HY-117605S
-
-
- HY-12388S1
-
desmethylclomipramine-d6; Norclomipramine-d6
|
Isotope-Labeled Compounds
Drug Metabolite
|
Neurological Disease
|
N-Desmethyl clomipramine-d6 (Desmethylclomipramine-d6) is deuterium labeled N-Desmethyl clomipramine. Desmethylclomipramine (Norclomipramine) is a metabolite of Clomipramine (HY-B0457A) and can be used for neurological research .
|
-
- HY-12388S
-
desmethylclomipramine-d7; Norclomipramine-d7
|
Isotope-Labeled Compounds
|
Neurological Disease
|
N-Desmethyl clomipramine-d7 (Desmethylclomipramine-d7) is deuterium labeled N-Desmethyl clomipramine. Desmethylclomipramine (Norclomipramine) is a metabolite of Clomipramine (HY-B0457A) and can be used for neurological research .
|
-
- HY-118788
-
-
- HY-131527
-
N-desmethyl Venlafaxine hydrochloride; Wy 45494
|
Serotonin Transporter
|
Metabolic Disease
|
Wy-45494 hydrochloride (N-Desmethyl Venlafaxine hydrochloride; Wy 45494) is a minor active metabolite of the selective norepinephrine and serotonin reuptake inhibitor (SNRI) venlafaxine. It is formed from venlafaxine via the cytochrome P450 (CYP) isomer CYP3A4.2. Wy-45494 hydrochloride inhibits norepinephrine and serotonin reuptake in rat synaptosomal preparations (IC50s of 4.7 and 1.6 μM, respectively). In vivo, Wy-45494 hydrochloride reversed reserpine-induced hypothermia in mice at a minimum effective dose (MED) of 10 mg/kg.
|
-
- HY-135331
-
|
Androgen Receptor
Cytochrome P450
|
Cancer
|
N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration .
|
-
- HY-135331S
-
|
Isotope-Labeled Compounds
Androgen Receptor
Cytochrome P450
|
Cancer
|
N-Desmethyl-Apalutamide-15N,d4 is the 15N and deuterium labeled isotope of N-Desmethyl-Apalutamide (HY-135331). N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration .
|
-
- HY-131527R
-
N-desmethyl Venlafaxine hydrochloride (Standard); Wy 45494 (Standard)
|
Serotonin Transporter
Reference Standards
|
Metabolic Disease
|
Wy-45494 (hydrochloride) (Standard) is the analytical standard of Wy-45494 (hydrochloride). This product is intended for research and analytical applications. Wy-45494 hydrochloride (N-Desmethyl Venlafaxine hydrochloride; Wy 45494) is a minor active metabolite of the selective norepinephrine and serotonin reuptake inhibitor (SNRI) venlafaxine. It is formed from venlafaxine via the cytochrome P450 (CYP) isomer CYP3A4.2. Wy-45494 hydrochloride inhibits norepinephrine and serotonin reuptake in rat synaptosomal preparations (IC50s of 4.7 and 1.6 μM, respectively). In vivo, Wy-45494 hydrochloride reversed reserpine-induced hypothermia in mice at a minimum effective dose (MED) of 10 mg/kg.
|
-
- HY-132647S
-
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl-4’-hydroxy Tamoxifen-d3 (E/Z Mixture) is the deuterium labeled N-Desmethyl-4’-hydroxy Tamoxifen (E/Z Mixture) .
|
-
- HY-131332S1
-
(11β)-11-[4-(Methylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate-d3
|
Isotope-Labeled Compounds
|
Others
|
N-Desmethyl ulipristal-d3 ((11β)-11-[4-(Methylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl-d3) acetate is deuterium labeled N-Desmethyl ulipristal acetate ((11β)-11-[4-(Methylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl) .
|
-
- HY-G0017R
-
Norimatinib (Standard); Imatinib metabolite N-desmethyl imatinib (Standard)
|
Reference Standards
Drug Metabolite
|
Others
|
Clobutinol (hydrochloride) (Standard) is the analytical standard of Clobutinol (hydrochloride). This product is intended for research and analytical applications. Clobutinol hydrochloride is a compound that has anti-tussive effects. Clobutinol hydrochloride affects heart rate and blood pressure, it can be used for cough related research .
|
-
- HY-W013775S
-
|
Isotope-Labeled Compounds
|
Others
|
9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid-d8 hydrochloride is the deuterium labeled 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride .
|
-
- HY-12388
-
desmethylclomipramine; Norclomipramine
|
Drug Metabolite
|
Neurological Disease
|
Desmethylclomipramine (Norclomipramine) is a metabolite of Clomipramine (HY-B0457A) and can be used for neurological research .
|
-
- HY-135392R
-
AC-279 (Standard)
|
Reference Standards
Drug Metabolite
|
Neurological Disease
|
Methyl 3,4-dihydroxybenzoate (Standard) is the analytical standard of Methyl 3,4-dihydroxybenzoate. This product is intended for research and analytical applications. Methyl 3,4-dihydroxybenzoate (Protocatechuic acid methyl ester; Methyl protocatechuate) is a major metabolite of antioxidant polyphenols found in green tea. Antioxidant and anti-inflammatory effect .
|
-
- HY-132709S
-
-
- HY-128038S
-
-
- HY-U00199
-
-
- HY-128038
-
|
Opioid Receptor
|
Neurological Disease
|
N-Desmethyl-loperamide is a major metabolite of loperamide, a drug that selectively activates peripheral μopioid receptors with a Ki value of 0.16 nM. N-Desmethyl-loperamide is a substrate of the ATP-dependent efflux transporter P-glycoprotein .
|
-
- HY-157207S
-
-
- HY-131629
-
-
- HY-172297
-
-
- HY-108226S1
-
-
- HY-144144S
-
-
- HY-143949S
-
-
- HY-139689S
-
|
Isotope-Labeled Compounds
|
Others
|
rac-trans-N-Desmethyl sertraline-d3 (hydrochloride) is the deuterium labeled rac-trans-N-Desmethyl sertraline hydrochloride .
|
-
- HY-143834S
-
-
- HY-W587542
-
|
Serotonin Transporter
|
Others
|
(1S,4S)-N-Desmethyl Sertraline (hydrochloride) is a metabolite of Sertraline. (1S,4S)-N-Desmethyl Sertraline (hydrochloride) is a selective serotonin uptake blocker with antidepressant properties .
|
-
- HY-158967
-
-
- HY-W753602
-
|
Isotope-Labeled Compounds
|
Neurological Disease
|
Acetamiprid-N-desmethyl- 13C,d3 is the 13C and deuterium labeled isotope of Acetamiprid-N-desmethyl( 13C,d3)(HY-B0823).Acetamiprid is a nAChR agonist that has been implicated in neuromuscular and reproductive disorders.
|
-
- HY-135161
-
|
Drug Metabolite
|
Others
|
EDDP perchlorate is an N-desmethyl metabolite of Methadone by intestinal, hepatic, and cytochrome P450 (CYP) 3A4 .
|
-
- HY-U00199A
-
(S)-N-desmethyl zopiclone; SEP-174559
|
GABA Receptor
nAChR
iGluR
|
Neurological Disease
|
(S)-Norzopiclone ((S)-N-Desmethyl zopiclone; SEP-174559) is a metabolite of Zopiclone with anxiolytic and anticonvulsant effects. (S)-Norzopiclone has benzodiazepine-like actions at γ2-bearing subtypes of the GABAA receptor and inhibits nACh and NMDA receptors .
|
-
- HY-146102
-
|
mAChR
|
Others
|
M1 ligand 1 (compound 3b-b) is a muscarinic acetylcholine receptor M1 ligand. M1 ligand 1 is a N-desmethyl congener of arecoline derivative. M1 ligand 1 can be used as PET (positron emission tomography) radiotracer .
|
-
- HY-N0913R
-
|
Endogenous Metabolite
Reference Standards
|
Others
|
Wy-45494 (hydrochloride) (Standard) is the analytical standard of Wy-45494 (hydrochloride). This product is intended for research and analytical applications. Wy-45494 hydrochloride (N-Desmethyl Venlafaxine hydrochloride; Wy 45494) is a minor active metabolite of the selective norepinephrine and serotonin reuptake inhibitor (SNRI) venlafaxine. It is formed from venlafaxine via the cytochrome P450 (CYP) isomer CYP3A4.2. Wy-45494 hydrochloride inhibits norepinephrine and serotonin reuptake in rat synaptosomal preparations (IC50s of 4.7 and 1.6 μM, respectively). In vivo, Wy-45494 hydrochloride reversed reserpine-induced hypothermia in mice at a minimum effective dose (MED) of 10 mg/kg.
|
-
- HY-P10828
-
|
Virus Protease
|
Infection
Inflammation/Immunology
|
MAPI is a polypeptide irreversible 3C cysteine protease (SV3CP) inhibitor. MAPI inhibits SV3CP by covalently binding its C-terminal Michael-acceptor extension to the active site thiol of SV3CP Cys 139. MAPI is promising for research of noroviruses infection .
|
-
- HY-P1108A
-
|
CFTR
|
Others
|
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B TFA antagonizes CRF2-mediated inhibition of gastric emptying .
|
-
- HY-P1108
-
|
CFTR
|
Others
|
Astressin 2B is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B antagonizes CRF2-mediated inhibition of gastric emptying .
|
-
- HY-P2592
-
-
- HY-P4521
-
|
MMP
|
Others
|
Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt is a MMP12 substrate, and can be used to detect MMP12 enzyme activity .
|
-
- HY-P3066
-
d(CH2)5Tyr(Et)VAVP
|
Vasopressin Receptor
|
Metabolic Disease
|
SKF 100398 (d(CH2)5Tyr(Et)VAVP), an arginine vasopressin (AVP) analogue, is a specific antagonist of the antidiuretic effect of exogenous and endogenous AVP .
|
-
- HY-125628
-
|
Endogenous Metabolite
|
Infection
|
Kahalalide A is an anti-mycobacterial compound with antimicrobial activity. Kahalalide A is derived from the marine mollusk Elysia rufescens. Kahalalide A has attracted extensive attention in natural product research due to its potential medicinal value .
|
-
- HY-P10272
-
PTG-300
|
Ferroportin
|
Others
|
Rusfertide is a peptide mimetic of natural hepcidin, which targets and degrades ferroportin, reduces serum iron and transferrin-saturation, and thus regulates the production of red blood cells. Rusfertide ameliorates the polycythemia vera, β-thalassemia and hereditary hemochromatosis .
|
-
- HY-A0248A
-
|
Bacterial
|
Infection
|
Polymyxin B1 is a potent antimicrobial lipopeptide first derived from Bacilus polymyxa. Polymyxin B1 is the major component in Polymyxin B (HY-A0248). Polymyxin B1 can induce lysis of bacterial cells through interaction with their membranes. Polymyxin B1 has the potential for multidrug-resistant Gram-negative bacterial infections treatment .
|
-
- HY-P10563
-
BHV-1100
|
CD38
|
Cancer
|
Noraramtide (BHV-1100) is an antibody recruitment molecule. Noraramtide can specifically bind to CD38 molecules to recruit natural killer (NK) cells. Noraramtide enhances the ability of NK cells to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while avoiding mutual killing between NK cells. Noraramtide can be used for the study of autologous cancer immunity .
|
-
Cat. No. |
Product Name |
Type |
-
- HY-W013775R
-
|
Biochemical Assay Reagents
|
N-Desmethyl ofloxacin (Standard) is the analytical standard of N-Desmethyl ofloxacin. This product is intended for research and analytical applications. N-Desmethyl ofloxacin is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
-
- HY-W013775
-
|
Biochemical Assay Reagents
|
N-Desmethyl ofloxacin is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
|
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P1108A
-
|
CFTR
|
Others
|
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B TFA antagonizes CRF2-mediated inhibition of gastric emptying .
|
-
- HY-P1108
-
|
CFTR
|
Others
|
Astressin 2B is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively. Astressin 2B antagonizes CRF2-mediated inhibition of gastric emptying .
|
-
- HY-P3066
-
d(CH2)5Tyr(Et)VAVP
|
Vasopressin Receptor
|
Metabolic Disease
|
SKF 100398 (d(CH2)5Tyr(Et)VAVP), an arginine vasopressin (AVP) analogue, is a specific antagonist of the antidiuretic effect of exogenous and endogenous AVP .
|
-
- HY-P10272
-
PTG-300
|
Ferroportin
|
Others
|
Rusfertide is a peptide mimetic of natural hepcidin, which targets and degrades ferroportin, reduces serum iron and transferrin-saturation, and thus regulates the production of red blood cells. Rusfertide ameliorates the polycythemia vera, β-thalassemia and hereditary hemochromatosis .
|
-
- HY-A0248A
-
|
Bacterial
|
Infection
|
Polymyxin B1 is a potent antimicrobial lipopeptide first derived from Bacilus polymyxa. Polymyxin B1 is the major component in Polymyxin B (HY-A0248). Polymyxin B1 can induce lysis of bacterial cells through interaction with their membranes. Polymyxin B1 has the potential for multidrug-resistant Gram-negative bacterial infections treatment .
|
-
- HY-P10828
-
|
Virus Protease
|
Infection
Inflammation/Immunology
|
MAPI is a polypeptide irreversible 3C cysteine protease (SV3CP) inhibitor. MAPI inhibits SV3CP by covalently binding its C-terminal Michael-acceptor extension to the active site thiol of SV3CP Cys 139. MAPI is promising for research of noroviruses infection .
|
-
- HY-P4756
-
|
Peptides
|
Others
|
N-(2-Carbamoyl-ethyl)-Val-Leu-anilide is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
|
-
- HY-P2592
-
-
- HY-P4521
-
|
MMP
|
Others
|
Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt is a MMP12 substrate, and can be used to detect MMP12 enzyme activity .
|
-
- HY-125628
-
|
Endogenous Metabolite
|
Infection
|
Kahalalide A is an anti-mycobacterial compound with antimicrobial activity. Kahalalide A is derived from the marine mollusk Elysia rufescens. Kahalalide A has attracted extensive attention in natural product research due to its potential medicinal value .
|
-
- HY-P10563
-
BHV-1100
|
CD38
|
Cancer
|
Noraramtide (BHV-1100) is an antibody recruitment molecule. Noraramtide can specifically bind to CD38 molecules to recruit natural killer (NK) cells. Noraramtide enhances the ability of NK cells to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while avoiding mutual killing between NK cells. Noraramtide can be used for the study of autologous cancer immunity .
|
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-70002AS
-
|
N-desmethyl Enzalutamide-d6 is a deuterium labeled N-desmethyl Enzalutamide. N-desmethyl Enzalutamide is an active metabolite of Enzalutamide. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
|
-
-
- HY-12388AS
-
|
N-Desmethyl Clomipramine-d3 (hydrochloride) is the deuterium labeled N-Desmethyl Clomipramine. N-Desmethyl Clomipramine hydrochloride (Desmethylclomipramine hydrochloride) is a primary plasma N-desmethyl metabolite of Clomipramine
|
-
-
- HY-143922S
-
|
N-Desmethyl Bedaquiline-d6 is the deuterium labeled N-Desmethyl Bedaquiline .
|
-
-
- HY-142283BS
-
|
N-Desmethyl dosimertinib-d5 is the deuterium labeled N-Desmethyl dosimertinib.
|
-
-
- HY-144143S
-
|
N-Desmethyl Olopatadine-d3 (hydrochloride) is the deuterium labeled N-Desmethyl Olopatadine hydrochloride .
|
-
-
- HY-158192S
-
|
N-Desmethyl diltiazem-d4 is deuterium labeled N-Desmethyl diltiazem .
|
-
-
- HY-132626S
-
|
N-Desmethyl Tamoxifen-d5 is the deuterium labeled N-Desmethyl Tamoxifen .
|
-
-
- HY-141750S1
-
|
N-Desmethyl Zolmitriptan-d3 is the deuterium labeled N-Desmethyl Zolmitriptan .
|
-
-
- HY-132685S
-
|
N-Desmethyl Topotecan-d3 is the deuterium labeled N-Desmethyl Topotecan .
|
-
-
- HY-132685AS
-
|
N-Desmethyl Topotecan-d3 hydrochloride is the deuterium labeled N-Desmethyl Topotecan hydrochloride .
|
-
-
- HY-132344S
-
|
N-Desmethyl asenapine-d4 (hydrochloride) is the deuterium labeled N-Desmethyl asenapine hydrochloride .
|
-
-
- HY-139519S
-
|
N-Desmethyl diphenhydramine-d3 (hydrochloride) is the deuterium labeled N-Desmethyl diphenhydramine hydrochloride .
|
-
-
- HY-132653S
-
|
N-Desmethyl Droloxifene-d5 is the deuterium labeled N-Desmethyl Droloxifene .
|
-
-
- HY-G0010S
-
|
N-desmethyl Netupitant-d6 is the deuterium labeled N-desmethyl Netupitant, which is a metabolite of Netupitant.
|
-
-
- HY-W754151
-
|
N-Desmethyl apalutamide-d4 is the deuterium-labeled N-Desmethyl-Apalutamide (HY-135331). N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration .
|
-
-
- HY-W741222S
-
|
N-Desmethyl Olopatadine-d6 is deuterium-labeled N-Desmethyl Olopatadine (HY-W741222) .
|
-
-
- HY-143810S
-
|
N-Desmethyl Mifepristone-d3 is the deuterium labeled N-Desmethyl Mifepristone . N-Desmethyl Mifepristone is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
-
- HY-W740049
-
|
N-Desmethyl rosuvastatin-d6 disodium salt is the deuterium labeled N-Desmethyl rosuvastatin disodium salt.
|
-
-
- HY-143767S
-
|
N-Desmethyl Azelastine-d4-1 is the deuterium labeled N-Desmethyl Azelastine .
|
-
-
- HY-Z3203S
-
|
N-Desmethyl Rosuvastatin-d6 (disodium) is the deuterium labeled N-Desmethyl Rosuvastatin disodium .
|
-
-
- HY-143931S
-
|
N-Desmethyl citalopram-d4 (oxalate) is the deuterium labeled N-Desmethyl citalopram oxalate .
|
-
-
- HY-G0017S
-
|
N-Desmethyl imatinib-d8 is a deuterium labeled Imatinib metabolite N-Desmethyl Imatinib.
|
-
-
- HY-W295339S
-
|
N-Desmethyl venlafaxine-d3 is a deuterium labeled compound.
|
-
-
- HY-100647S
-
|
N-Desmethyl Nefopam-d4 (hydrochloride) is deuterium labeled N-Desmethylnefopam (hydrochloride).
|
-
-
- HY-W709612
-
|
Regorafenib N-oxide and N-desmethyl (M5)-d3-1 (N-Desmethyl regorafenib N-oxide-d3-1) is the deuterium labeled Regorafenib N-oxide and N-desmethyl (M5) (HY-108226). Regorafenib N-oxide and N-desmethyl (M5) (N-Desmethyl regorafenib N-oxide) is an active metabolite of Sorafenib (HY-10201) and can be metabolized by CYP3A4 .
|
-
-
- HY-120422S
-
|
N-Desmethyl Regorafenib-d3 is deuterium labeled BAY-751098.
|
-
-
- HY-144386S
-
|
N-Desmethyl L-ergothioneine methyl ester-d6 is the deuterium labeled N-Desmethyl L-ergothioneine methyl ester .
|
-
-
- HY-G0017S1
-
|
N-Desmethyl imatinib-d4 is the deuterium-labeled N-Desmethyl imatinib (HY-G0017). N-Desmethyl imatinib-d4 (Norimatinib) is a metabolite of Imatinib (HY-15463). Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR .
|
-
-
- HY-108226S
-
|
Regorafenib N-oxide and N-desmethyl (M5)-d3 is deuterium labeled Regorafenib N-oxide and N-desmethyl (M5).
|
-
-
- HY-118788S
-
|
N-Desmethyl rosiglitazone-d4 is the deuterium labeled N-Desmethyl rosiglitazone .
|
-
-
- HY-118601S
-
|
N-Desmethyl Pirenzepine-d8 is the deuterium labeled N-Desmethyl Pirenzepine .
|
-
-
- HY-W741626
-
|
N-Desmethyl selegiline-d5 is the deuterium labeled N-Desmethyl selegiline .
|
-
-
- HY-U00199S
-
|
N-Desmethyl zopiclone-d8 is deuterium labeled Norzopiclone. Norzopiclone is the inactive metabolite of Zopiclone. Norzopiclone has some anxiolytic properties.
|
-
-
- HY-150544S
-
|
N-Desmethyl Selegiline-dd5 hydrochloride is the deuterium labeled N-Desmethyl Selegiline hydrochloride . N-Desmethyl Selegiline-d5 hydrochloride is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
-
-
- HY-135392S
-
|
N-Desmethyl Pimavanserin-d9 hydrochloride (AC-279-d9 hydrochloride) is the deuterium labeled N-Desmethyl Pimavanserin (HY-135392). N-Desmethyl Pimavanserin is the active metabolite of Pimavanserin. Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively .
|
-
-
- HY-W740183
-
|
N-Desmethyl prochlorperazine dimaleate-d8 is the deuterium labeled 2-Chloro-10-(3-(piperazin-1-yl)propyl)-10H-phenothiazine (HY-W722908).
|
-
-
- HY-117605S
-
|
N-Desmethyl Sildenafil-d8 is the deuterium labeled N-Desmethyl Sildenafil (HY-117605). N-Desmethyl Sildenafil is a major metabolite of Sildenafil. Sildenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor .
|
-
-
- HY-12388S1
-
|
N-Desmethyl clomipramine-d6 (Desmethylclomipramine-d6) is deuterium labeled N-Desmethyl clomipramine. Desmethylclomipramine (Norclomipramine) is a metabolite of Clomipramine (HY-B0457A) and can be used for neurological research .
|
-
-
- HY-12388S
-
|
N-Desmethyl clomipramine-d7 (Desmethylclomipramine-d7) is deuterium labeled N-Desmethyl clomipramine. Desmethylclomipramine (Norclomipramine) is a metabolite of Clomipramine (HY-B0457A) and can be used for neurological research .
|
-
-
- HY-135331S
-
|
N-Desmethyl-Apalutamide-15N,d4 is the 15N and deuterium labeled isotope of N-Desmethyl-Apalutamide (HY-135331). N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration .
|
-
-
- HY-132647S
-
|
N-Desmethyl-4’-hydroxy Tamoxifen-d3 (E/Z Mixture) is the deuterium labeled N-Desmethyl-4’-hydroxy Tamoxifen (E/Z Mixture) .
|
-
-
- HY-131332S1
-
|
N-Desmethyl ulipristal-d3 ((11β)-11-[4-(Methylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl-d3) acetate is deuterium labeled N-Desmethyl ulipristal acetate ((11β)-11-[4-(Methylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl) .
|
-
-
- HY-W013775S
-
|
9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid-d8 hydrochloride is the deuterium labeled 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride .
|
-
-
- HY-132709S
-
|
N-Desmethyl-diltiazem-d4 (hydrochloride) is the deuterium labeled N-Desmethyl-diltiazem hydrochloride .
|
-
-
- HY-128038S
-
|
N-Desmethyl-loperamide-d3 is the deuterium labeled N-Desmethyl-loperamide .
|
-
-
- HY-157207S
-
|
N-Desmethyl-Atomoxetine labeled-d5 hydrochloride is the deuterium labeled N-Desmethyl-Atomoxetine labeled hydrochloride .
|
-
-
- HY-108226S1
-
|
Regorafenib N-oxide and N-desmethyl (M5)- 13C6 is the 13C-labeled Regorafenib N-oxide and N-desmethyl (M5) .
|
-
-
- HY-144144S
-
|
(E)-N-Desmethyl Olopatadine-d3 (hydrochloride) is the deuterium labeled (E)-N-Desmethyl Olopatadine.
|
-
-
- HY-143949S
-
|
(Rac)-N-desmethyl Dapoxetine-d7 hydrochloride is the deuterium labeled (Rac)-N-desmethyl Dapoxetine hydrochloride .
|
-
-
- HY-139689S
-
|
rac-trans-N-Desmethyl sertraline-d3 (hydrochloride) is the deuterium labeled rac-trans-N-Desmethyl sertraline hydrochloride .
|
-
- HY-143834S
-
|
O-Desacetyl-N-desmethyl Diltiazem-d3 is the deuterium labeled O-Desacetyl-N-desmethyl Diltiazem .
|
-
- HY-W753602
-
|
Acetamiprid-N-desmethyl- 13C,d3 is the 13C and deuterium labeled isotope of Acetamiprid-N-desmethyl( 13C,d3)(HY-B0823).Acetamiprid is a nAChR agonist that has been implicated in neuromuscular and reproductive disorders.
|
-
Cat. No. |
Product Name |
|
Classification |
-
- HY-150544S
-
(-)-N-desmethylselegiline-d5 hydrochloride
|
|
Alkynes
|
N-Desmethyl Selegiline-dd5 hydrochloride is the deuterium labeled N-Desmethyl Selegiline hydrochloride . N-Desmethyl Selegiline-d5 hydrochloride is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: